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.2013.02.Abstract Congenital muscular dystrophies (CMD) are a group of heterogeneous inherited autoso-
mal recessive disorders characterized by muscular weakness, hypotonia and contractures. The Mer-
osin Negative CMD (MNCMD) is considered to be the most severe form and is usually associated
with white matter abnormalities as seen with brain imaging. Merosin is also expressed in the ner-
vous system and its deﬁciency could affect its development. This article describes the clinical picture,
muscle biopsy ﬁndings and neuroimaging abnormalities of eight Egyptian Pediatric patients with
the clinical presentation of merosin negative congenital muscular dystrophy. The leading clinical
presentation in almost all patients was severe hypotonia, muscular weakness and failure to achieve
motor developmental milestones, only Case 2 walked at 2 years of age. Mentality was normal in
most patients with exception of Case 2 in whom scholastic achievement was poor and was associ-
ated with behavior abnormality. Serum Creatine kinase ranged from moderate to severe elevation,
536–3563 U/L, Electromyography demonstrated a myopathic pattern in all patients. Brain MRI
showed extensive demyelination of the cerebral white matter in 6/8 patients with extension to cer-
ebellar demyelination in Case 5. 5/8 patients underwent muscle biopsy for which immunoﬂuores-
cence staining for merosin demonstrated complete deﬁciency of laminin a2 in Case 5 & partial
deﬁciency of laminin a2 in Case 2.aila Abdel moteleb Selim).
onal Research Center, Egypt.
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Figure 1 Flair Brain MRI of Case 1
centrum semiovale (right) (Arrows).
62 L.A.m. Selim et al.This report demonstrates the utility of Immunoﬂuorescence staining as a guide to conﬁrm the
diagnosis of MDCMD especially when molecular diagnosis is not available.
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Congenital muscular dystrophy (CMD) is a heterogeneous
group of disorders, characterized by early onset muscle weak-
ness, hypotonia and contractures [13]. There are several types
of CMD with heterogeneous aetiology, one form is the Fukuy-
ama type CMD with severe structural brain anomalies which
has been mapped to chromosome 9q31-33. The pure form of
CMD can be further subdivided into merosin positive and
merosin negative CMD (MNCMD) [3].
Congenital muscular dystrophy (CMD) due to merosin
(laminin alpha2 chain) deﬁciency is an autosomal recessive dis-
order characterized by severe muscular weakness, hypotonia
since birth, absence of overt cerebral or ocular symptoms
and muscle pathology consistent with a dystrophic process
[1]. It had been suggested to account for 50% of all cases of
CMDs [12]. The aim of this work was to describe the clinical,
neuroimaging, and immune-histochemical features of eight
pediatric patients who presented clinically to the Cairo Univer-
sity Children Hospital (CUCH) with MNCMD.2. Case reports
2.1. Family 1, Cases 1, 2, 3
Family 1, Case 1, A 7 years old boy, the second child of ﬁrst
degree consanguineous parents, was born preterm by ventouse
delivery after an uneventful pregnancy. He was cyanosed at
birth and was incubated for 20 days. At birth he was noticed
to be ﬂoppy. Social smile and mother recognition were present
at 2 months of age. He presented to the neuropediatric clinic of
the CUCH at the age of 2 years because of failure of achieve-
ment of his motor developmental milestones. Neurological
examination revealed generalized hypotonia, diminished deep
tendon reﬂexes, muscle power grade 3/6, weak facial muscula-
ture as well as generalized muscle wasting. Patient was able to
support his head and sit unsupported but no standing nor
walking. Speech was normal as well as mentality. His brain
Magnetic Resonance Imaging (MRI) revealed extensive demy-
elination of the white matter Fig. 1. His Electromyographic
(EMG) studies revealed myopathic pattern. Nerve Conductionshowing bilateral diffuse cerebralVelocity (NCV) demonstrated features of neuropathic
affection. His lab investigations showed marked elevated of
Creatine Kinase (CK), 935 (reference interval: 21–232 U/L).
Case 2, The younger brother of Case 1, is a 3 years old male
presenting with the same but milder clinical picture. His Ck
was moderately increased, 532 U/L. His EMG was myopathic.
Brain Computed tomography (CT) showed non-speciﬁc in-
creased hypodensity in the white matter of the right parieto-
occipital region. Brain MRI done by the age of 5 months
and proved to be normal. There are no other affected members
in the same family Fig. 2. Case 3, the youngest sister, a
4 months old female presented with generalized hypotonia
and marked head lag, her CK was markedly elevated,
2600 U/L. Brain MRI showed extensive demyelination.
2.2. Family 2, Cases 4 & 5
Family 2, Case 4 is a 7 years old male boy, the ﬁrst son of a
ﬁrst degree consanguineous couple. He presented to the neuro-
pediatric clinic at the CUCH at the age of 20 months with glo-
bal developmental delay and generalized hypotonia. His
prenatal history was uneventful, he was delivered by Cesarean
section, with history of cyanosis due to umbilical cord strangu-
lation. Neurological examination revealed a ﬂoppy infant with
severe generalized hypotonia manifested by marked head lag
on traction response, ventral suspension showed the limbs
hanging limply and vertical suspension revealed marked shoul-
der girdle hypotonia. Cranial nerve examination revealed no
ptosis or external ophthalmoplegia with normal visual ﬁxation
and visual following movements, no difﬁculty in mastication
or swallowing and normal Auditory Brain Stem Evoked Pote-
nial (ABrSEP). Clinical Examination revealed no organomeg-
aly nor cardiomyopathy. His lab investigations showed
markedly elevated CK: 1831 U/L. EMG showed a myopathic
pattern. Brain MRI done by the age of 2 years revealed an
extensive demyelination suggestive of leukodystrophy, particu-
larly at the frontal, parietal and occiptal regions Fig. 3. Based
on the MRI ﬁndings, a leukodystrophy enzyme assay proﬁle
was performed including Aryl Sulfatase, N Acetyl Aspartatic
acid, serum Very Long Chain Fatty Acids (VLCFA) and all
were in the normal range. Plasma lactate was normal,
1.5 mmol/L (Normal; up to 2.2 mmol/L). Muscle biopsydemyelination in the deep periventricular white matter (left) and in
Figure 2 Family pedigree of Cases (1, 2, 3). P: Proband.
Figure 3 T2W brain MRI of Case 4 showing bilateral symmet-
ric, diffuse, abnormal high signal intensity in the white matter of
both cerebral hemispheres involving mainly the deep periventric-
ular white matter (Arrow).
Figure 4 Family pedigree of Cases (4, 5). P: Proband.
Figure 5 Brain MRI of Case 7 showed irregular high signal
intensity involving the white matter of both occipital and
peritrigonal regions on the T2WIs(Arrow).
Figure 6 Family pedigree of Cases (6, 7). P: Proband, M:
Months.
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replacement of muscle ﬁbres by fat and ﬁbrous tissue with
the presence of advanced nonspeciﬁc atrophic changes.
Case 5, 1.5 years old female, the younger sister of Case 4,
presented to the CUPH because of failure of proper achieve-
ment of her motor developmental milestones. She was noticed
by the mother to be ﬂoppy after birth. Neurological Examina-
tion revealed ﬂoppy infant with severe generalized hypotonia.
Cranial nerve examination was normal with no ptosis nor
external ophthalmoplegia, normal visual following movement
and normal ﬁxation, mastication and swallowing were intact.
Normal hearing documented by normal ABrSEP. Abdominal
examination did not reveal organomegaly. Cardiac examina-
tion and Echocardiography (ECHO) were normal. Her lab
investigations showed markedly elevated CK, 1831 U/L.
EMG showed myopathic changes and MRI done by the age
of 1 year, demonstrated extensive demyelination involving
mainly periventricular white matter in both cerebral hemi-spheres as well as in cerebellar peduncles. No other affected
member in the same family Fig. 4.
2.3. Family 3, Cases 6, 7
Family 3, Case 6, A 6 years old girl, the 3rd child of consan-
guineous parents. She was born by normal delivery, full term.
The condition started by the age of 4 months where the mother
noticed that the girl has delayed development, poor suckling
and muscle weakness. Clinical examination showed severe
hypotonia. EMG by the age of 9 months revealed myopathic
pattern. ECHO was normal. CK was markedly elevated
1561 U/L. Plasma lactate was normal. Brain MRI done by
the age of 2 years showed bilateral periventricular deep white
matter areas of bright T2 and ﬂuid-attenuated inversion recov-
ery (FLAIR) signal intensity suggestive of demyelinating dis-
ease. Muscle biopsy done by the age of 1 year, Light
microscopic examination showed extensive fat deposition,
marked degeneration and necrosis of the muscle ﬁbres. immu-
noﬂuorescence (IF) staining showed normal dystrophin stain-
ing, normal Sarcoglycans staining and negative staining of
merosin conﬁrming MDCMD (results are not shown).
Case 7, the younger sister of Case 6, a 3 years old girl. She
suffered the same clinical picture but with more progressive
coarse. CK was elevated, 707 U/L. Plasma lactate was normal,
0.2 mmol/L. Brain MRI done by the age of 2 years showed
irregular high signal intensity involving the white matter of
both occipital and peritrigonal regions on the T2 Weighted
Figure 7 Brain MRI of Case 8 showed extensive demyelination changes of both cerebral hemispheres appearing as high signal intensity
on T2WI images (arrows).
Figure 8 Family pedigree of Case 8. P: Proband, WK: Week,
SB: Stillbirth.
64 L.A.m. Selim et al.Images (WIs) Fig. 5. There are two sibs who died by the age of
5 and 7 months, however the cause of death is not known
Fig. 6.
2.4. Family 4, Case 8
Family 4, Case 8, A 5 years old boy, the 2nd child of ﬁrst de-
gree consanguineous parents, was born by normal vaginal
delivery after an uneventful pregnancy. He developed recur-
rent episodes of chest infections since the age of one month.
At the age of 6 months, he was noticed to be hypotonic, with
inability to support his head. He presented to the CUCH at the
age of one year because of failure to achieve his motor devel-
opmental milestones. Physical examination revealed an alert
infant, but he was hypotonic with decreased spontaneous
movements, he had complete had lag, with facial weakness,
weak cry, swallowing and mastication. His body weight was
at 5th centile and he has a proximal muscle power of grade
2/6 with generalized muscle wasting. Tendon Achilles was tight
and deep tendon reﬂexes were markedly diminished. Ocular
motility and fundus examination were normal, Auditory
evoked potential (AEP) demonstrated a bilateral sensoryneu-
ral hearing loss with evidence of demyelination from the co-
chlea to the lower pons. At the age of 4 years, he was able to
support his head, sit unsupported, but no walking nor standing
with normal intelligence and speech. CK was elevated 536 U/
L, Plasma lactate was normal. His metabolic screening was
normal as well as enzymatic assay of Aryl Sulphatase andVLCFA.ECHO was normal. Brain MRI showed extensive
demyelination changes of both cerebral hemispheres (including
deep periventricular white matter, subcortical U ﬁbers and
centrum semiovale) in the form of low SI on TI WI and high
signal intensity on T2WI & FLAIR images Fig. 7. EMG
showed early recruitment, low amplitude, and brief duration
of polyphasic motor unit potential, yet, the motor NCV stud-
ies were normal. Muscle biopsy showed prominent fatty and
ﬁbrous tissue replacement of muscle ﬁbers, and the preserved
ﬁbers exhibited variation in diameter. There was no relevant
inﬂammatory cell inﬁltration and the intermyoﬁbrillary archi-
tecture was unremarkable. Electron microscopy showed loss of
myoﬁlaments and replacement by structureless material, these
ﬁndings were consistent with progressive muscular dystrophy.
Gomori trichome stain showed no ragged red ﬁbres. There was
no family history of neuromuscular disease, however the ﬁrst
baby was stillborn and a younger normal male sib Fig. 8.
3. Materials and methods
An open biopsy from the quadriceps femoris was performed in
5/8 patients under general anesthesia. All biopsies were taken
after oral informed consent obtained from the parents of the
diseased patients. Muscle biopsy specimens were snap frozen
in liquid nitrogen then stored at 80 C until processed. For
the diagnosis of MDCMD, Immunoﬂuorescence (IF) staining
was performed on cryosections of all biopsy specimens from
the probands along with negative control muscle biopsy spec-
imens. Brieﬂy, 7-mm thick Cryosections were air-dried for 1 h.
The sections were then incubated for 1 h at room temperature
with the following antibodies: the rat monoclonal anti-merosin
(Alexis Co., San Diego, California, USA) diluted 1:1000 and
the mouse monoclonal antibody (MAB1922, Chemicon
International, Inc., Temecula, California, USA) diluted
1:2000. The ﬁrst antibody recognizes the human merosin
300 kDa fragment at the amino-terminal and the second anti-
body recognizes the merosin 80 kDa fragment towards the car-
boxy-terminal. Sections washed in 0.1% Tween-20/ phosphate-
buffered saline (PBS) and then incubated with anti-rat and
anti-mouse biotinylated IgG (Amersham Pharmacia Biotech
Inc., Piscataway, USA), respectively, diluted 1:40 for 30 min.
After three washes in Tween-20/ PBS, the binding reaction
was detected with streptavidin ﬂuorescein (Amersham Phar-
macia Biotech Inc., Piscataway, USA) at 1:250 dilution for
30 min. All antibody dilutions were made in PBS (pH 7.4) con-
Figure 9 shows negative immunoﬂurescence staining Merosin
300 kd subunit (Ampliﬁed 40X) of Case 5.
Figure 10 shows negative immunoﬂurescence staining of Mer-
osin 80 kDa subunit (Ampliﬁed 40X) of Case 5.
Figure 11 shows positive immunoﬂurescence staining of Mero-
sin 80 kDa subunit (Ampliﬁed 40X) of Case 2.
Figure 12 shows reduced immunoﬂurescence staining of Mero-
sin 300 kDa subunit (Ampliﬁed 40X) of Case 2.
Table 1 Summary of the demographic and clinical data of the studied patients.
Pedigree/case N Age at presentation in month Gender Consanguinity Walking Hypotonia Ocular motility Mental
subnormality
P1/1 24 M Positive Not achieved Severe Normal Normal
P1/2 36 M Not achieved Mild Normal Poor scholastic
achievement,
poor memoy
P1/3 4 F Not achieved Moderate Normal Behaviour
abnormalities
P2/4 20 M Positive Not achieved Severe Normal Normal
P2/5 18 F Not achieved Severe Normal NA
P3/6 4 F Positive NA Severe Normal NA
P3/7 3 F NA Severe Normal NA
P4/8 6 M Positive not achieved Severe Normal NA
P: pedigree, M: Male, F: Female, NA: Not Available.
Merosin deﬁcient congenital muscular dystrophy: Clinical, neuroimaging and immunohistochemical study of 8 Egyptian 65taining 1% bovine serum albumin (BSA) (Sigma–Aldrich,
St. Louis, Mo.). Sections were mounted in glycerol/PBS 1:1
and examined under a Zeiss microscope equipped for
epiﬂuorescence.
4. Results
Eight Egyptian patients from 4 different families (4 females &
4 males) had been included in this study. Their ages of presen-
tation ranged from 3 to 36 months (Mean ± SD: 14 ± 11).
The leading clinical presentation in almost all patients was se-
vere hypotonia and failure to achieve motor developmental
milestones, only Case 2 walked at 2 years of age. Mentality
was normal in most patients with exception of Case 2 in whomscholastic achievement was poor and associated with behavior
abnormality, positive consanguinity was elicited for all pa-
tients (Table 1). Serum Creatine kinase ranged from moderate
to severe elevation, 536–3563 IU (Mean ± 2SD: 1533 ± 1033)
(Table 2). Electromyography performed in all patients demon-
strated a myopathic pattern. Brain MRI showed extensive
demyelination of the cerebral white matter in 6/8 patients with
extension to cerebellar demyelination in Case 5 (Table 2). 5/8
patients underwent muscle biopsy for which IF staining for
merosin was applied. We were able to demonstrate complete
deﬁciency of laminin a2 in Case 5, there was no immunostain-
ing on muscle ﬁbers with the anti-300 kDa antibody (Fig. 9)
and the anti-80 kDa antibody (Fig. 10) & partial deﬁciency
of laminin a2 in Case 2, the 80 kDa epitope was preserved
(Fig. 11), but the 300 kDa epitope was reduced (Fig. 12). Such
results conﬁrmed the diagnosis of MDCMD. Muscle biopsy
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66 L.A.m. Selim et al.specimens from patients 1, 4 and 8 showed marked degenera-
tion of muscle ﬁbres and extensive replacement with fatty and
ﬁbrous tissue elements interfering with IF staining. Demo-
graphic, clinical, neuroimaging, laboratory and IF staining re-
sults are summarized in (Tables 1 and 2).
5. Discussion
Congenital muscular dystrophies (CMDs), a heterogeneous
group of inherited muscle disorders, characterized by a combi-
nation of early onset hypotonia and weakness, contractures,
variable progression, normal or elevated CK, and myopathic
changes on EMG, usually associated with a dystrophic muscle
biopsy [11,18]. This group of conditions is thought to be
among the most common of autosomal recessive neuromuscu-
lar disorders [17].
There are two categories of CMD depending on the struc-
tural involvement of the central nervous system (CNS) [10].
The classic form of CMD has no apparent clinical involve-
ment of the CNS and the patient has normal intellect [10].
MNCMD is a severe form characterized by the absence of
laminin a2 chain (formerly named merosin) around muscle ﬁ-
bres [13]. Most patients have normal intelligence but some
have been reported to show mental retardation and epilepsy.
They form a clinically homogeneous subgroup, in contrast
to partial merosin deﬁciency cases who are less frequent, of
variable severity but generally less severe [1].
In 1994, Tome et al. reported the ﬁrst group of patients
with classic CMD that were also deﬁcient in merosin [15].
The merosin-negative cases showed clinical homogeneity with
symptoms of severe hypotonia, multiple contractures, delayed
developmental milestones and normal mentation accompanied
by variable degrees of central hypomyelination as seen with
neuroimaging [5,6]. Both complete and partial deﬁciency of
the protein had been described and those with milder symp-
toms were associated with the partial form [14].
Merosin deﬁcient congenital muscular dystrophy
(MDCMD) was clinically suspected in the studied patients
as they presented with early onset severe hypotonia, motor-
developmental delay with increased CK levels, especially in
the early months of life, no independent ambulation due to
weakness and contractures and respiratory insufﬁciency which
may need tracheotomy and abnormal cerebral imaging ﬁnd-
ings [3].
Although merosin-negative CMD cases demonstrate clini-
cal homogeneity, the severity of weakness and CNS manifesta-
tion may vary. Patients with MNCMD are likely to develop
dilated cardiomyopathy or right bundle branch block [6]. In
this report, none of patients had cariac abnormalities. How-
ever, In a literature search on 248 reported cases, ECG or
ECHO results were abnormal in 35% of the cases [5].
Brain MRI ﬁndings, which are found in almost all patients
of MDCMD may be a valuable criterion for diagnosis. Char-
acteristic white matter hypodensity was seen on brain MRI
with high T2 signal in the periventricular and subcortical
white matter [16]. EMG and NCS is performed in all patients
with suspected CMD for conﬁrmation of myopathy and exclu-
sion of other diseases. NCS results are normal except in some
cases of MDC1A, in which mild neuropathic changes may be
seen. EMG changes usually show myopathic pattern and
found early in all types of CMD [2]. In this report, all patients
Merosin deﬁcient congenital muscular dystrophy: Clinical, neuroimaging and immunohistochemical study of 8 Egyptian 67showed normal pattern at NCV and myopathic pattern at
EMG.
MNCMD is caused by mutations in the LAMA2 gene on
chromosome 6q22–23 [7]. This gene is composed of 65 exons
and at least 90 different mutations have been reported
(http://www.dmd.nl/). Diagnosis of MDCMD is usually made
by the clinical features and immunohistochemical examination
of muscle biopsy. Using several antibodies directed against dif-
ferent regions of laminin a2 chain allows a precise distinction
between complete and partial deﬁciency [4]. As there are nei-
ther common mutations nor hot spots for mutations, the
detection of causative genetic abnormality is laborious, expen-
sive and time consuming [7]. Accordingly, the immunohisto-
chemical staining analysis of the muscle biopsies is a
powerful diagnostic tool [1].
In the current study, 7/8 patients presented with severe
hypotonia and hyporeﬂexia and was not able to achieve inde-
pendent walking due to weakness and contractures, only Case
2 from Family 1, had mild motor delay and achieved walking
at the age of 2 years, motor power assessment revealed a good
muscle power of grade 4/5. This patient has poor scholastic
achievement, poor memory as well as attention deﬁcient hyper-
active disorder. These parameters could not be assessed in
other patients as their severe motor handicap prevented them
from school attendance, however attempts performed by par-
ents for education of these children reports a good response
indicating a normal mentality despite extensive demyelinating
process relevant to the brain MRI of 7 cases in contrast to mild
nonspeciﬁc posterior demyelination in the brain MRI of Case
2, F1, so it seems that no correlation exist between the extent
of demyelination and the mental affection.
Case 2, Family 1, is mostly suffering from partial merosin
deﬁciency as the patient could achieve complete independent
ambulation at the age of 2 years with grade 4/5 muscle power,
he has mild mental subnormality and mild brain demyelina-
tion. Partial merosin deﬁciency can be due to LAMA2 defects
or to other causes [1]. To our knowledge, all cases with partial
merosin deﬁciency, normal intelligence and white matter
changes are due to a primary LAMA2 defect [4]. But a few
cases with primary partial merosin deﬁciency may present a
slight mental retardation, epilepsy and/or very mild occipital
cortex or cerebellum abnormalities in addition to the charac-
teristic white matter changes [9]. Their precise diagnosis is then
difﬁcult in absence of a molecular conﬁrmation as they can be
mistaken for other disorders [7].
Results of the present study were in concordance with the
results of Talim et al., 2000 who studied 76 patients from 70
families based on the immunohistochemical or linkage analy-
sis, 39 were merosin deﬁcient and 37 merosin positive. Simi-
larly, the age of presentation of the Merosin deﬁcient
patients was younger than 2 years of age. Also, the average
values of Ck level was high, 2021 IU/L and 26 patients in their
studies had white matter hypodensity [13].
In the series of the probands of the present study, brain
MRI in patients 1,2,3 showed diffuse extensive white matter
signal-changes. In patient 4, there was no abnormal white mat-
ter changes on brain MRI at 5 months of age despite of con-
ﬁrming the diagnosis of MDCMD by IF. This ﬁnding
underscores the age at which MRI is performed, because
MRI changes may be hard to see in the early stages of the dis-
ease, with incomplete cerebral myelination. These abnormal
white matter lesions are generally detectable after six monthsof age [3]. Also if brain MRI ﬁndings in early infancy (usually
before four months of age) are normal in a child suspected of
having MDCMD, repeated imaging studies after the age of
one year should be very useful in evaluating white matter
abnormalities.
6. Conclusion
To the best of knowledge, this is the ﬁrst reported cases of
MNCMD in Egypt. In this report, we demonstrated the utility
of IF staining as a guide to reach the diagnosis and further
molecular testing. As Egypt is a country with high consanguin-
ity, autosomal recessive genetic disorders are very common.
Further studies are highly recommended to estimate the prev-
alence of MDCMD among Egyptian patients. Also, Further
molecular genetic analysis is recommended for better assess-
ment of the phenotype/genotype correlation, genetic counsel-
ing and prenatal diagnosis.Acknowledgements
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